Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Invested Capital (2016 - 2023)

Historic Invested Capital for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to $81.2 million.

  • Cellectis' Invested Capital rose 68216.59% to $81.2 million in Q3 2023 from the same period last year, while for Dec 2023 it was $15.6 million, marking a year-over-year decrease of 9360.5%. This contributed to the annual value of $243.4 million for FY2022, which is N/A changed from last year.
  • Per Cellectis' latest filing, its Invested Capital stood at $81.2 million for Q3 2023, which was up 68216.59% from $101.7 million recorded in Q2 2023.
  • Over the past 5 years, Cellectis' Invested Capital peaked at $463.9 million during Q4 2020, and registered a low of $5.2 million during Q1 2023.
  • Over the past 5 years, Cellectis' median Invested Capital value was $217.6 million (recorded in 2022), while the average stood at $214.5 million.
  • Over the last 5 years, Cellectis' Invested Capital had its largest YoY gain of 68216.59% in 2023, and its largest YoY loss of 4696.24% in 2023.
  • Cellectis' Invested Capital (Quarter) stood at $400.5 million in 2019, then increased by 15.83% to $463.9 million in 2020, then crashed by 34.83% to $302.3 million in 2021, then dropped by 19.48% to $243.4 million in 2022, then tumbled by 66.65% to $81.2 million in 2023.
  • Its Invested Capital stands at $81.2 million for Q3 2023, versus $101.7 million for Q2 2023 and $5.2 million for Q1 2023.